APVO · Aptevo Therapeutics Inc. · Investor Relations
$0.40
-0.01 (-3.36%)
At close · Nov 20
Return incl. dividend (before tax)
Going-concern doubt
— flagged Nov 16, 2026
Substantial doubt about the company's ability to continue as a going concern.
“When considered in aggregate, these factors raise substantial doubt about our ability to continue as a going concern for the one-year period from the date of issuance of these financial statements.”View the 10-Q filed Nov 16, 2026
Market Cap
$1.43M
Shares
3.46M
Volume · Nov 20
95.64K
Avg daily vol (3M)
130.94K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Recent news
Past events
| Date | Event | Type |
|---|---|---|
| 2025-12-09 | ASH 2025 – 67th American Society of Hematology Annual Meeting & Exposition | Shareholder meeting |
| 2025-11-12 | BIO-Europe 2025 – 31st Annual International Partnering Conference | Conference |
| 2025-11-09 | SITC 2025 – 40th Anniversary Annual Meeting | Shareholder meeting |
| 2025-10-09 | 4th Annual ROTH Healthcare Opportunities Conference | Conference |
Key facts
CIK
1671584
CUSIP
03835L702
13F (30d)
14 filings
12 filers
Visit website
Investor relations